|
US12203938B2
(en)
|
|
Levetiracetam immunoassays
|
|
AU2005200717B2
(en)
|
|
2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
|
|
US9095557B2
(en)
|
|
Anticonvulsant combination therapy
|
|
JP2025102814A
(ja)
|
|
発毛を調節するための組成物及び方法
|
|
US20180125818A1
(en)
|
|
Methods and compositions for treating schizophrenia
|
|
AU2002340971A1
(en)
|
|
Use of 2-oxo-1-pyrrolidine derivatives for the treatment of dyskinesia and movement disorders
|
|
US20090131508A1
(en)
|
|
Use of 2-Oxo-1-Pyrrolidone Derivatives for the Preparation of a Drug
|
|
EP2968220A4
(en)
|
|
METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTIONS
|
|
CN109932442A
(zh)
|
|
一种布瓦西坦异构体的检测方法
|
|
KR20170007528A
(ko)
|
|
２―옥소―１―피롤리딘 유도체를 포함하는 연장 방출 제형
|
|
US12559456B2
(en)
|
|
Method for preparing levetiracetam and intermediates thereof
|
|
PL4036244T3
(pl)
|
|
Enzymatyczny sposób wytwarzania kwasu (2s)-2-[(4r)-2-oxo-4-propylo-pirolidyn-1-ylo]masłowego i jego przemiana w briwaracetam
|
|
EP1619182A1
(en)
|
|
Substance exhibiting antidepressant property
|
|
RU2003110288A
(ru)
|
|
Вещество, обладающее антидепрессивной активностью
|
|
RU2699669C1
(ru)
|
|
Новые составы N-карбамоилметил-4-фенил-2-пирролидона
|
|
US20240409511A1
(en)
|
|
Process for the production of levetiracetam and intermediates thereof
|
|
JP6453632B2
(ja)
|
|
環状アミドアクリレート含有組成物およびその製造方法
|